Zobrazeno 1 - 10
of 319
pro vyhledávání: '"Guntram, Schernthaner"'
The management of type 2 diabetes before, during and after Covid-19 infection: what is the evidence?
Publikováno v:
Cardiovascular Diabetology, Vol 20, Iss 1, Pp 1-11 (2021)
Abstract Patients with Covid-19 place new challenges on the management of type 2 diabetes, including the questions of whether glucose-lowering therapy should be adjusted during infection and how to manage a return to normal care after resolution of C
Externí odkaz:
https://doaj.org/article/0dafb8b6594847eebbfd1bdddfd35c76
Autor:
Guntram Schernthaner, Naim Shehadeh, Alexander S. Ametov, Anna V. Bazarova, Fahim Ebrahimi, Peter Fasching, Andrej Janež, Péter Kempler, Ilze Konrāde, Nebojša M. Lalić, Boris Mankovsky, Emil Martinka, Dario Rahelić, Cristian Serafinceanu, Jan Škrha, Tsvetalina Tankova, Žydrūnė Visockienė
Publikováno v:
Cardiovascular Diabetology, Vol 19, Iss 1, Pp 1-17 (2020)
Abstract The disclosure of proven cardiorenal benefits with certain antidiabetic agents was supposed to herald a new era in the management of type 2 diabetes (T2D), especially for the many patients with T2D who are at high risk for cardiovascular and
Externí odkaz:
https://doaj.org/article/0e1a0b51ae0646099e803da351dd7ca0
Autor:
Guntram Schernthaner, Avraham Karasik, Agnė Abraitienė, Alexander S. Ametov, Zsolt Gaàl, Janusz Gumprecht, Andrej Janež, Susanne Kaser, Katarina Lalić, Boris N. Mankovsky, Evgeny Moshkovich, Marju Past, Martin Prázný, Gabriela Radulian, Lea Smirčić Duvnjak, Ivan Tkáč, Kārlis Trušinskis
Publikováno v:
Cardiovascular Diabetology, Vol 18, Iss 1, Pp 1-9 (2019)
Abstract EMPA-REG OUTCOME is recognised by international guidelines as a landmark study that showed a significant cardioprotective benefit with empagliflozin in patients with type 2 diabetes (T2D) and cardiovascular disease. To assess the impact of e
Externí odkaz:
https://doaj.org/article/8d398bf5b3cb4286a35496a80a088901
Autor:
Johanna Maria Brix, Hans-Peter Kopp, Florian Höllerl, Gerit Holger Schernthaner, Bernhard Ludvik, Guntram Schernthaner
Publikováno v:
Obesity Facts, Vol 12, Iss 4, Pp 397-406 (2019)
Objectives: The frequency of postprandial hypoglycaemia after different operative procedures of bariatric surgery (BS) is unknown, although this complication is potentially dangerous. Predictors and severity of hypoglycaemia after Roux-en-Y gastric b
Externí odkaz:
https://doaj.org/article/caaa31d9a9c34f85a0c6b4a93d4bc8f2
Autor:
Guntram Schernthaner, Heinz Drexel, Evgeny Moshkovich, Birute Zilaitiene, Emil Martinka, Leszek Czupryniak, Tamás Várkonyi, Andrej Janež, Kristine Ducena, Katarina Lalić, Tsvetalina Tankova, Martin Prázný, Lea Smirčić Duvnjak, Olga Sukhareva, Harald Sourij
Publikováno v:
BMC Endocrine Disorders, Vol 19, Iss 1, Pp 1-13 (2019)
Abstract Background For patients with type 2 diabetes (T2D), cardiovascular disease (CVD) is the single most common cause of mortality. In 2008 and 2012, the Federal Drug Administration (FDA) and the European Medicines Agency (EMA) respectively manda
Externí odkaz:
https://doaj.org/article/0272f69452424381adfcfdd3590cbea1
Autor:
Guntram Schernthaner, Chaim Lotan, Elina Baltadzhieva-Trendafilova, Jonas Ceponis, Martin Clodi, Kristine Ducena, Eva Goncalvesova, Cristian Guja, Marek Honka, Andrej Janež, Nebojša Lalić, Roger Lehmann, Noémi Nyolczas, Priit Pauklin, Andrzej Rynkiewicz, Igor Sergienko, Lea Smirčić Duvnjak
Publikováno v:
Cardiovascular Diabetology, Vol 17, Iss 1, Pp 1-6 (2018)
Abstract Cardiovascular disease (CVD) is the most significant prognostic factor in individuals with type 2 diabetes (T2D). However, a significant number of individuals may develop CVD that does not present with the classic angina-related or heart fai
Externí odkaz:
https://doaj.org/article/f7662e14a56f43069b7ffbdcfeadece8
Autor:
Martin Clodi, Heidemarie Abrahamian, Helmut Brath, Guntram Schernthaner, Johann Brix, Bernhard Ludvik, Heinz Drexel, Christoph H. Saely, Peter Fasching, Gersina Rega-Kaun, Bernhard Föger, Claudia Francesconi, Elke Fröhlich-Reiterer, Alexandra Kautzky-Willer, Jürgen Harreiter, Anton Luger, Michael Resl, Michaela Riedl, Yvonne Winhofer, Sabine E. Hofer, Friedrich Hoppichler, Joakim Huber, Susanne Kaser, Claudia Ress, Monika Lechleitner, Felix Aberer, Julia K. Mader, Harald Sourij, Hermann Toplak, Bernhard Paulweber, Lars Stechemesser, Thomas Pieber, Rudolf Prager, Harald Stingl, Thomas Stulnig, Birgit Rami-Merhar, Michael Roden, Christian Schelkshorn, Thomas C. Wascher, Raimund Weitgasser, Sandra Zlamal-Fortunat
Publikováno v:
Wiener klinische Wochenschrift. 135:32-44
ZusammenfassungDie Hyperglykämie ist wesentlich an der Entstehung der Spätkomplikationen bei an Diabetes mellitus Typ 2 erkrankten Patienten/Patientinnen beteiligt. Während Lebensstilmaßnahmen die Eckpfeiler jeder Diabetestherapie bleiben, benöt
Autor:
Christoph H. Saely, Gerit-Holger Schernthaner, Johanna Brix, Renate Klauser-Braun, Emanuel Zitt, Heinz Drexel, Guntram Schernthaner
Publikováno v:
Wiener klinische Wochenschrift. 135:147-156
ZusammenfassungHypertonie ist eine sehr häufige Komorbidität bei Patient:innen mit Diabetes mellitus, die – wenn unzureichend behandelt – signifikant zur erhöhten Mortalität und zum Auftreten von mikrovaskulären und makrovaskulären Komplika
Autor:
Guntram Schernthaner
Publikováno v:
Diabetes & Metabolism Journal, Vol 45, Iss 4, Pp 615-616 (2021)
Externí odkaz:
https://doaj.org/article/671982993e8942a9999f0430bb572b8d
Autor:
Guntram Schernthaner, Roger Lehmann, Martin Prázný, Leszek Czupryniak, Kristine Ducena, Peter Fasching, Andrej Janež, Avraham Karasik, Peter Kempler, Emil Martinka, Marina V. Shestakova, Lea Smirčić Duvnjak, Tsvetalina Tankova
Publikováno v:
Cardiovascular Diabetology, Vol 16, Iss 1, Pp 1-12 (2017)
Abstract Aims These recommendations aim to improve care for patients with type 2 diabetes (T2D) at high cardiovascular (CV) risk in Central and Eastern Europe. Cardiovascular disease (CVD) and/or chronic kidney disease (CKD) are major interdependent
Externí odkaz:
https://doaj.org/article/a98d192fce5b47699289f36bd5e7e85e